One postdoctoral position is available in the Bonaldi Laboratory ("Nuclear Proteomics") at the Department of Experimental Oncology of the European Institute of Oncology (IEO), Milan, Italy. The initial appointment will be for one year, renewable based on performance and project needs.
The successful candidate will join the AIRC Investigator Grant 2023 (IG2023) project: "Dissecting the Impact of Protein-Methylation Signaling in Sustaining Epithelial Ovarian Cancer Adaptive Chemoresistance (ProMeSSA)".
The project aims to dissect how protein arginine methylation signaling networks contribute to the establishment and maintenance of adaptive chemoresistance in epithelial ovarian cancer. Combining state-of-the-art mass spectrometry-based proteomics, modification-proteomics, molecular and cellular biology, biochemistry, and multi-omics data integration, the project seeks to uncover novel mechanisms underlying cancer cell plasticity and therapy adaptation.
The Bonaldi Laboratory has internationally recognized expertise in epigenetics, protein methylation signaling, and mass spectrometry-based proteomics, with a particular focus on understanding how post-translational modifications regulate gene expression programs in cancer and other biological systems.
The successful candidate will work within a highly collaborative and multidisciplinary environment and will interact with national and international collaborators in the fields of proteomics, cancer biology, epigenetics, and computational biology.
We are seeking an enthusiastic, highly motivated and scientifically ambitious postdoctoral researcher with a strong commitment to academic research and a clear interest in developing an independent scientific career.